Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization

doi:10.1084/jem.169.3.603

This Article

Full Text (PDF, 667K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Carbone, F. R.

Articles by Bevan, M. J.

Search for Related Content

PubMed

PubMed Citation

Articles by Carbone, F. R.

Articles by Bevan, M. J.

Pubmed/NCBI databases

Hazardous Substances DB
Compound via MeSH
Substance via MeSH
CYANOGEN BROMIDE
Medline Plus Health Information
Dietary Proteins
Immunization

Social Bookmarking

What's this?

ARTICLES

Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization

FR Carbone and MJ Bevan
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

CTL recognize peptide forms of processed, foreign antigens in association with class I molecules encoded by the MHC and are usually directed against endogenously synthesized "cellular antigens," such as those expressed by virus-infected cells. In vitro studies have shown that small exogenous peptides can directly associate with class I molecules on the cell surface and mimic the target complex derived by intracellular processing and presentation. We have recently generated OVA-specific, H-2Kb-restricted CTL by immunizing C57BL/6 mice with a syngeneic tumor line transfected with the OVA cDNA. The CTL recognize the OVA transfectant E.G7-OVA and the synthetic peptide OVA258-276, but fail to recognize the native protein. We reasoned that given the potential for direct peptide/class I association observed in vitro, OVA258-276 may induce CTL after in vivo priming. However, we found that this is not the case. OVA258-276 and peptides of increasing lengths up to OVA242-276 and OVA242-285, which are all able to form the target complex in vitro, are inefficient at priming E.G7-OVA-specific CTL responses after intravenous injection. This is also true for both native and denatured OVA. In contrast to these results the synthetic peptide OVA229-276 corresponding to a peptide in a partial tryptic digestion of OVA can efficiently prime C57BL/6 mice in vivo after intravenous injection. This peptide elicits CTL that appear identical to those derived from animals immunized with syngeneic cells producing OVA endogenously. These results are discussed in terms of separate class I and class II antigen presentation pathways and the ability of only certain, exogenous antigens to enter the cytoplasmic, class I pathway.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Jordan, K. A., Wilson, E. H., Tait, E. D., Fox, B. A., Roos, D. S., Bzik, D. J., Dzierszinski, F., Hunter, C. A. (2009). Kinetics and Phenotype of Vaccine-Induced CD8+ T-Cell Responses to Toxoplasma gondii. Infect. Immun. 77: 3894-3901 [Abstract] [Full Text]
Tellam, J., Smith, C., Rist, M., Webb, N., Cooper, L., Vuocolo, T., Connolly, G., Tscharke, D. C., Devoy, M. P., Khanna, R. (2008). From the Cover: Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc. Natl. Acad. Sci. USA 105: 9319-9324 [Abstract] [Full Text]
Lind, E. F., Ahonen, C. L., Wasiuk, A., Kosaka, Y., Becher, B., Bennett, K. A., Noelle, R. J. (2008). Dendritic Cells Require the NF-{kappa}B2 Pathway for Cross-Presentation of Soluble Antigens. J. Immunol. 181: 354-363 [Abstract] [Full Text]
Elzey, B. D., Schmidt, N. W., Crist, S. A., Kresowik, T. P., Harty, J. T., Nieswandt, B., Ratliff, T. L. (2008). Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood 111: 3684-3691 [Abstract] [Full Text]
Wakabayashi, A., Nakagawa, Y., Shimizu, M., Moriya, K., Nishiyama, Y., Takahashi, H. (2008). Suppression of an Already Established Tumor Growing through Activated Mucosal CTLs Induced by Oral Administration of Tumor Antigen with Cholera Toxin. J. Immunol. 180: 4000-4010 [Abstract] [Full Text]
Truscott, S. M., Lybarger, L., Martinko, J. M., Mitaksov, V. E., Kranz, D. M., Connolly, J. M., Fremont, D. H., Hansen, T. H. (2007). Disulfide Bond Engineering to Trap Peptides in the MHC Class I Binding Groove. J. Immunol. 178: 6280-6289 [Abstract] [Full Text]
Taqueti, V. R., Grabie, N., Colvin, R., Pang, H., Jarolim, P., Luster, A. D., Glimcher, L. H., Lichtman, A. H. (2006). T-bet Controls Pathogenicity of CTLs in the Heart by Separable Effects on Migration and Effector Activity. J. Immunol. 177: 5890-5901 [Abstract] [Full Text]
Hervas-Stubbs, S., Majlessi, L., Simsova, M., Morova, J., Rojas, M.-J., Nouze, C., Brodin, P., Sebo, P., Leclerc, C. (2006). High Frequency of CD4+ T Cells Specific for the TB10.4 Protein Correlates with Protection against Mycobacterium tuberculosis Infection.. Infect. Immun. 74: 3396-3407 [Abstract] [Full Text]
Cai, Y. H., Alvarez, A., Alcaide, P., Duramad, P., Lim, Y.-C., Jarolim, P., Lowe, J. B., Luscinskas, F. W., Lichtman, A. H. (2006). Abrogation of Functional Selectin-Ligand Expression Reduces Migration of Pathogenic CD8+ T Cells into Heart.. J. Immunol. 176: 6568-6575 [Abstract] [Full Text]
Su, H., Chang, D. S., Gambhir, S. S., Braun, J. (2006). Monitoring the Antitumor Response of Naive and Memory CD8 T Cells in RAG1-/- Mice by Positron-Emission Tomography. J. Immunol. 176: 4459-4467 [Abstract] [Full Text]
Diaz-de-Durana, Y., Mantchev, G. T., Bram, R. J., Franco, A. (2006). TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo. Blood 107: 594-601 [Abstract] [Full Text]
Medoff, B. D., Seung, E., Wain, J. C., Means, T. K., Campanella, G. S.V., Islam, S. A., Thomas, S. Y., Ginns, L. C., Grabie, N., Lichtman, A. H., Tager, A. M., Luster, A. D. (2005). BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. JEM 202: 97-110 [Abstract] [Full Text]
Schlecht, G., Garcia, S., Escriou, N., Freitas, A. A., Leclerc, C., Dadaglio, G. (2004). Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation. Blood 104: 1808-1815 [Abstract] [Full Text]
Wang, X., Lybarger, L., Connors, R., Harris, M. R., Hansen, T. H. (2004). Model for the Interaction of Gammaherpesvirus 68 RING-CH Finger Protein mK3 with Major Histocompatibility Complex Class I and the Peptide-Loading Complex. J. Virol. 78: 8673-8686 [Abstract] [Full Text]
Grabie, N., Hsieh, D. T., Buono, C., Westrich, J. R., Allen, J. A., Pang, H., Stavrakis, G., Lichtman, A. H. (2003). Neutrophils Sustain Pathogenic CD8+ T Cell Responses in the Heart. Am. J. Pathol. 163: 2413-2420 [Abstract] [Full Text]
Oran, A. E., Robinson, H. L. (2003). DNA Vaccines, Combining Form of Antigen and Method of Delivery to Raise a Spectrum of IFN-{gamma} and IL-4-Producing CD4+ and CD8+ T Cells. J. Immunol. 171: 1999-2005 [Abstract] [Full Text]
Lybarger, L., Yu, Y. Y. L., Miley, M. J., Fremont, D. H., Myers, N., Primeau, T., Truscott, S. M., Connolly, J. M., Hansen, T. H. (2003). Enhanced Immune Presentation of a Single-chain Major Histocompatibility Complex Class I Molecule Engineered to Optimize Linkage of a C-terminally Extended Peptide. J. Biol. Chem. 278: 27105-27111 [Abstract] [Full Text]
Kawamura, K. S., Su, R.-C., Nguyen, L. T., Elford, A. R., Ohashi, P. S., Gariepy, J. (2002). In Vivo Generation of Cytotoxic T Cells from Epitopes Displayed on Peptide-Based Delivery Vehicles. J. Immunol. 168: 5709-5715 [Abstract] [Full Text]
Yu, Y. Y. L., Netuschil, N., Lybarger, L., Connolly, J. M., Hansen, T. H. (2002). Cutting Edge: Single-Chain Trimers of MHC Class I Molecules Form Stable Structures That Potently Stimulate Antigen-Specific T Cells and B Cells. J. Immunol. 168: 3145-3149 [Abstract] [Full Text]
Mattner, F., Fleitmann, J.-K., Lingnau, K., Schmidt, W., Egyed, A., Fritz, J., Zauner, W., Wittmann, B., Gorny, I., Berger, M., Kirlappos, H., Otava, A., Birnstiel, M. L., Buschle, M. (2002). Vaccination with Poly-L-Arginine As Immunostimulant for Peptide Vaccines: Induction of Potent and Long-Lasting T-Cell Responses against Cancer Antigens. Cancer Res. 62: 1477-1480 [Abstract] [Full Text]
Schlecht, G., Leclerc, C., Dadaglio, G. (2001). Induction of CTL and Nonpolarized Th Cell Responses by CD8{alpha}+ and CD8{alpha}- Dendritic Cells. J. Immunol. 167: 4215-4221 [Abstract] [Full Text]
Lefrancois, L., Vezys, V. (2001). Transgenic Mouse Model of Intestine-Specific Mucosal Injury and Repair. J Natl Cancer Inst Monogr 2001: 21-25 [Abstract] [Full Text]
Fayolle, C., Osickova, A., Osicka, R., Henry, T., Rojas, M.-J., Saron, M.-F., Sebo, P., Leclerc, C. (2001). Delivery of Multiple Epitopes by Recombinant Detoxified Adenylate Cyclase of Bordetella pertussis Induces Protective Antiviral Immunity. J. Virol. 75: 7330-7338 [Abstract] [Full Text]
Lybarger, L., Yu, Y. Y. L., Chun, T., Wang, C.-R., Grandea, A. G. III, Van Kaer, L., Hansen, T. H. (2001). Tapasin Enhances Peptide-Induced Expression of H2-M3 Molecules, but Is Not Required for the Retention of Open Conformers. J. Immunol. 167: 2097-2105 [Abstract] [Full Text]
Tindle, R. W., Herd, K., Doan, T., Bryson, G., Leggatt, G. R., Lambert, P., Frazer, I. H., Street, M. (2001). Nonspecific Down-Regulation of CD8+ T-Cell Responses in Mice Expressing Human Papillomavirus Type 16 E7 Oncoprotein from the Keratin-14 Promoter. J. Virol. 75: 5985-5997 [Abstract] [Full Text]
Haque, M. A., Hawes, J. W., Blum, J. S. (2001). Cysteinylation of MHC Class II Ligands: Peptide Endocytosis and Reduction Within APC Influences T Cell Recognition. J. Immunol. 166: 4543-4551 [Abstract] [Full Text]
Chan, K., Lee, D. J., Schubert, A., Tang, C. M., Crain, B., Schoenberger, S. P., Corr, M. (2001). The Roles of MHC Class II, CD40, and B7 Costimulation in CTL Induction by Plasmid DNA. J. Immunol. 166: 3061-3066 [Abstract] [Full Text]
Myers, N. B., Harris, M. R., Connolly, J. M., Lybarger, L., Yu, Y. Y. L., Hansen, T. H. (2000). Kb, Kd, and Ld Molecules Share Common Tapasin Dependencies as Determined Using a Novel Epitope Tag. J. Immunol. 165: 5656-5663 [Abstract] [Full Text]
Corr, M., von Damm, A., Lee, D. J., Tighe, H. (1999). In Vivo Priming by DNA Injection Occurs Predominantly by Antigen Transfer. J. Immunol. 163: 4721-4727 [Abstract] [Full Text]
Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., Ohta, A. (1999). Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo. JEM 190: 617-628 [Abstract] [Full Text]
Ludewig, B., Oehen, S., Barchiesi, F., Schwendener, R. A., Hengartner, H., Zinkernagel, R. M. (1999). Protective Antiviral Cytotoxic T Cell Memory Is Most Efficiently Maintained by Restimulation Via Dendritic Cells. J. Immunol. 163: 1839-1844 [Abstract] [Full Text]
Saito, N. G., Chang, H.-C., Paterson, Y. (1999). Recognition of an MHC Class I-Restricted Antigenic Peptide Can Be Modulated by para-Substitution of Its Buried Tyrosine Residues in a TCR-Specific Manner. J. Immunol. 162: 5998-6008 [Abstract] [Full Text]
Morgan, D. J., Kurts, C., Kreuwel, H. T.�C., Holst, K. L., Heath, W. R., Sherman, L. A. (1999). Ontogeny of T cell tolerance to peripherally expressed antigens. Proc. Natl. Acad. Sci. USA 96: 3854-3858 [Abstract] [Full Text]
Bianco, A., Brock, C., Zabel, C., Walk, T., Walden, P., Jung, G. (1998). New Synthetic Non-peptide Ligands for Classical Major Histocompatibility Complex Class I Molecules. J. Biol. Chem. 273: 28759-28765 [Abstract] [Full Text]
Su, R.-C., Kung, S. K. P., Gariepy, J., Barber, B. H., Miller, R. G. (1998). NK Cells Can Recognize Different Forms of Class I MHC. J. Immunol. 161: 755-766 [Abstract] [Full Text]
White, D. W., Harty, J. T. (1998). Perforin-Deficient CD8+ T Cells Provide Immunity to Listeria monocytogenes by a Mechanism That Is Independent of CD95 and IFN-{gamma} but Requires TNF-{alpha}. J. Immunol. 160: 898-905 [Abstract] [Full Text]
Suzue, K., Zhou, X., Eisen, H. N., Young, R. A. (1997). Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc. Natl. Acad. Sci. USA 94: 13146-13151 [Abstract] [Full Text]
Ben-Shahar, S., Cassouto, B., Novak, L., Porgador, A., Reiss, Y. (1997). Production of a Specific Major Histocompatibility Complex Class I-restricted Epitope by Ubiquitin-dependent Degradation of Modified Ovalbumin in Lymphocyte Lysate. J. Biol. Chem. 272: 21060-21066 [Abstract] [Full Text]
Bennett, S. R.M., Carbone, F. R., Karamalis, F., Miller, J. F.A.P., Heath, W. R. (1997). Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help. JEM 186: 65-70 [Abstract] [Full Text]
Lanzavecchia, A (1993). Identifying strategies for immune intervention. Science 260: 937-944 [Abstract]
Ulmer, J., Donnelly, J., Parker, S., Rhodes, G., Felgner, P., Dwarki, V., Gromkowski, S., Deck, R., DeWitt, C., Friedman, A, et, al. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745-1749 [Abstract]
Fremont, D., Matsumura, M, Stura, E., Peterson, P., Wilson, I. (1992). Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257: 919-927 [Abstract]
Matsumura, M, Fremont, D., Peterson, P., Wilson, I. (1992). Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257: 927-934 [Abstract]
Vitiello, A, Potter, T., Sherman, L. (1990). The role of beta 2-microglobulin in peptide binding by class I molecules. Science 250: 1423-1426 [Abstract]
Rock, K., Gamble, S, Rothstein, L (1990). Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249: 918-921 [Abstract]
Etlinger, H., Gillessen, D, Lahm, H., Matile, H, Schonfeld, H., Trzeciak, A (1990). Use of prior vaccinations for the development of new vaccines. Science 249: 423-425 [Abstract]
Hosken, N., Bevan, M. (1990). Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science 248: 367-370 [Abstract]
Carbone, F.R., Hosken, N.A., Moore, M.W., Bevan, M.J. (1989). Class I MHC-restricted Cytotoxic Responses to Soluble Protein Antigen. Cold Spring Harb Symp Quant Biol 54: 551-555 [Abstract]
Nishikawa, H., Tanida, K., Ikeda, H., Sakakura, M., Miyahara, Y., Aota, T., Mukai, K., Watanabe, M., Kuribayashi, K., Old, L. J., Shiku, H. (2001). Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity. Proc. Natl. Acad. Sci. USA 98: 14571-14576 [Abstract] [Full Text]